2 million antibody products . Find yours today
View products

1 matching Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 antibodies for Immunoprecipitation from 13 suppliers

Superstar Kits

Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 information

Aliases

Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 is also known as CD158I, KI2S4, KIR2DS4, KKA3, MHC class I NK cell receptor, NKAT-8, NKAT8, p58 NK receptor CL-39/CL-17

0 Applications, 0 Species currently selected

All  None               
  WB External link   IHC-P External link   ELISA External link   IHC-F External link   IF External link   FACS External link   ICC External link
Human  External link   28      11       9       8       4       2       1   

View matching ELISA Kits

1 matching Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 antibodies for Immunoprecipitation after applying filters

Click each Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 antibody that interests you to view the full Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 antibody datasheet.
View only Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 Monoclonal Antibodies or Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 Polyclonal Antibodies
Santa Cruz Biotechnology

Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 antibodies


sc-59279 Mouse Anti-Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 4 antibody, Monoclonal[5F2]
100 ug Hu
IP, WB
Datasheet

Antibody Resource

Antibody Resource is the premier source of antibody and elisa products from the major suppliers.

Unit 3 The Bury, Newmarket Road, Stow-Cum-Quy, Cambridgeshire CB25 9AQ, United Kingdom

+44 1223 813746

antibody@antibodyresource.com

Copyright 1997-2024 Zing Ventures. All rights reserved

FIND US ON